HEADER NUCLEAR PROTEIN 19-OCT-18 6ILQ TITLE CRYSTAL STRUCTURE OF PPARGAMMA WITH COMPOUND BR101549 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PPAR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 8 CHAIN: B; COMPND 9 SYNONYM: NCOA-1,CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 74,BHLHE74, COMPND 10 PROTEIN HIN-2,RIP160,RENAL CARCINOMA ANTIGEN NY-REN-52,STEROID COMPND 11 RECEPTOR COACTIVATOR 1,SRC-1; COMPND 12 EC: 2.3.1.48; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-G(PPAR-G), TRANSCRIPTION KEYWDS 2 FACTOR, LIGAND-BINDING DOMAIN, STEROID RECEPTOR COACTIVATOR-1, KEYWDS 3 NUCLEAR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR E.HONG,T.H.JANG,J.CHIN,K.H.KIM,W.JUNG,S.H.KIM REVDAT 2 22-NOV-23 6ILQ 1 REMARK REVDAT 1 11-SEP-19 6ILQ 0 JRNL AUTH W.CHOUNG,H.J.JUNG,D.YANG,E.H.NAM,H.CHOI,B.R.LEE,M.PARK, JRNL AUTH 2 S.M.JANG,J.S.LIM,W.S.KIM,K.H.KIM,J.CHIN,K.JUNG,G.LEE,E.HONG, JRNL AUTH 3 T.H.JANG,J.MYUNG,S.H.KIM JRNL TITL IDENTIFICATION OF BR101549 AS A LEAD CANDIDATE OF NON-TZD JRNL TITL 2 PPAR GAMMA AGONIST FOR THE TREATMENT OF TYPE 2 DIABETES: JRNL TITL 3 PROOF-OF-CONCEPT EVALUATION AND SAR. JRNL REF BIOORG.MED.CHEM.LETT. V. 29 631 2019 JRNL REFN ESSN 1464-3405 JRNL PMID 30594432 JRNL DOI 10.1016/J.BMCL.2018.12.043 REMARK 2 REMARK 2 RESOLUTION. 2.41 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.14_3260: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.41 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.44 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 10936 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.304 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1097 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 25.4400 - 4.8057 0.87 1168 126 0.2285 0.3079 REMARK 3 2 4.8057 - 3.8186 0.97 1237 139 0.1763 0.2483 REMARK 3 3 3.8186 - 3.3371 1.00 1261 134 0.1986 0.2926 REMARK 3 4 3.3371 - 3.0325 1.00 1269 143 0.2291 0.3329 REMARK 3 5 3.0325 - 2.8154 1.00 1242 135 0.2505 0.3373 REMARK 3 6 2.8154 - 2.6496 1.00 1242 146 0.2435 0.3438 REMARK 3 7 2.6496 - 2.5171 1.00 1245 131 0.2438 0.3245 REMARK 3 8 2.5171 - 2.4076 0.96 1175 143 0.2531 0.3396 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.350 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2120 REMARK 3 ANGLE : 0.912 2863 REMARK 3 CHIRALITY : 0.047 337 REMARK 3 PLANARITY : 0.004 355 REMARK 3 DIHEDRAL : 5.966 1740 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -21.5237 -9.5726 15.3419 REMARK 3 T TENSOR REMARK 3 T11: 0.3612 T22: 0.3780 REMARK 3 T33: 0.2472 T12: 0.0084 REMARK 3 T13: 0.0054 T23: 0.0313 REMARK 3 L TENSOR REMARK 3 L11: 3.8505 L22: 3.8432 REMARK 3 L33: 2.8779 L12: 0.7414 REMARK 3 L13: 0.8796 L23: 1.4744 REMARK 3 S TENSOR REMARK 3 S11: -0.0296 S12: 0.1255 S13: -0.1139 REMARK 3 S21: 0.0295 S22: 0.1744 S23: -0.1145 REMARK 3 S31: 0.2051 S32: 0.2734 S33: -0.1412 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ILQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 30-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1300009401. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAY-17 REMARK 200 TEMPERATURE (KELVIN) : 277 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 6B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97950 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10939 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.408 REMARK 200 RESOLUTION RANGE LOW (A) : 25.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.09336 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 30.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.41 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.38380 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3KMG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M MGCL2, 0.1 M TRIS 8.5 PH, 27 REMARK 280 %W/V PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.42200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.42200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 26.82350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 42.62850 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 26.82350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 42.62850 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 61.42200 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 26.82350 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 42.62850 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 61.42200 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 26.82350 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 42.62850 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 657 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 206 REMARK 465 ASP A 243 REMARK 465 LYS A 244 REMARK 465 GLY A 258 REMARK 465 GLU A 259 REMARK 465 ASP A 260 REMARK 465 LYS A 261 REMARK 465 ILE A 262 REMARK 465 LYS A 263 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 465 LYS A 275 REMARK 465 GLU A 276 REMARK 465 ASP A 462 REMARK 465 MET A 463 REMARK 465 TYR A 477 REMARK 465 CYS B 676 REMARK 465 PRO B 677 REMARK 465 SER B 678 REMARK 465 SER B 679 REMARK 465 HIS B 680 REMARK 465 SER B 681 REMARK 465 GLU B 696 REMARK 465 GLY B 697 REMARK 465 SER B 698 REMARK 465 PRO B 699 REMARK 465 SER B 700 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 224 CE NZ REMARK 470 ASN A 253 CG OD1 ND2 REMARK 470 MET A 256 CG SD CE REMARK 470 ARG A 280 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 343 CG CD OE1 OE2 REMARK 470 GLU A 351 CG CD OE1 OE2 REMARK 470 ARG A 357 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 358 CG CD CE NZ REMARK 470 ASP A 362 CG OD1 OD2 REMARK 470 ASP A 396 OD1 OD2 REMARK 470 ASP A 441 OD1 OD2 REMARK 470 LYS A 457 CD CE NZ REMARK 470 THR A 461 CB OG1 CG2 REMARK 470 SER A 464 CB OG REMARK 470 GLU A 471 CG CD OE1 OE2 REMARK 470 GLU B 685 CG CD OE1 OE2 REMARK 470 LYS B 688 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 208 -66.48 69.27 REMARK 500 LEU A 393 50.71 -90.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 657 DISTANCE = 6.42 ANGSTROMS REMARK 525 HOH A 658 DISTANCE = 6.45 ANGSTROMS REMARK 525 HOH A 659 DISTANCE = 6.86 ANGSTROMS REMARK 525 HOH A 660 DISTANCE = 7.07 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AE0 A 501 DBREF 6ILQ A 206 477 UNP P37231 PPARG_HUMAN 234 505 DBREF 6ILQ B 676 700 UNP Q15788 NCOA1_HUMAN 676 700 SEQRES 1 A 272 PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU SEQRES 2 A 272 TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA SEQRES 3 A 272 LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SEQRES 4 A 272 SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET MET SEQRES 5 A 272 GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU SEQRES 6 A 272 GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN SEQRES 7 A 272 GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE SEQRES 8 A 272 THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU SEQRES 9 A 272 ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL SEQRES 10 A 272 HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU MET ASN SEQRES 11 A 272 LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET SEQRES 12 A 272 THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY SEQRES 13 A 272 ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE SEQRES 14 A 272 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE SEQRES 15 A 272 ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU SEQRES 16 A 272 LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU SEQRES 17 A 272 LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO SEQRES 18 A 272 GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET SEQRES 19 A 272 THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU SEQRES 20 A 272 LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SER LEU SEQRES 21 A 272 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR SEQRES 1 B 25 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS SEQRES 2 B 25 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER HET AE0 A 501 39 HETNAM AE0 ETHYL [2-BUTYL-6-OXO-1-{[2'-(5-OXO-4,5-DIHYDRO-1,2,4- HETNAM 2 AE0 OXADIAZOL-3-YL)[1,1'-BIPHENYL]-4-YL]METHYL}-4-(PROPAN- HETNAM 3 AE0 2-YL)-1,6-DIHYDROPYRIMIDIN-5-YL]ACETATE FORMUL 3 AE0 C30 H34 N4 O5 FORMUL 4 HOH *63(H2 O) HELIX 1 AA1 SER A 208 PHE A 226 1 19 HELIX 2 AA2 THR A 229 THR A 238 1 10 HELIX 3 AA3 ASP A 251 MET A 257 1 7 HELIX 4 AA4 ALA A 278 SER A 302 1 25 HELIX 5 AA5 GLY A 305 LEU A 309 5 5 HELIX 6 AA6 ASP A 310 LEU A 333 1 24 HELIX 7 AA7 ARG A 350 SER A 355 1 6 HELIX 8 AA8 PRO A 359 PHE A 363 5 5 HELIX 9 AA9 MET A 364 ALA A 376 1 13 HELIX 10 AB1 ASP A 380 LEU A 393 1 14 HELIX 11 AB2 ASN A 402 HIS A 425 1 24 HELIX 12 AB3 GLN A 430 GLU A 460 1 31 HELIX 13 AB4 HIS A 466 LYS A 474 1 9 HELIX 14 AB5 HIS B 687 GLN B 695 1 9 SHEET 1 AA1 3 PHE A 247 ILE A 249 0 SHEET 2 AA1 3 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 AA1 3 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 CISPEP 1 LYS A 358 PRO A 359 0 4.61 SITE 1 AC1 13 PHE A 226 CYS A 285 ARG A 288 SER A 289 SITE 2 AC1 13 ALA A 292 MET A 329 LEU A 333 VAL A 339 SITE 3 AC1 13 ILE A 341 SER A 342 GLU A 343 MET A 364 SITE 4 AC1 13 HIS A 449 CRYST1 53.647 85.257 122.844 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018640 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011729 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008140 0.00000